NASDAQ | ETF
The fund uses a "passive management" approach to track the performance, before fees and expenses, of the index.
The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH.
Under normal circumstances, the fund will invest at least 80% of the fund"s net assets in component securities that make up the index.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 12.31% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 9.60% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.14% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.90% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.83% |
| NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 4.67% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.61% |
| ROP | Roche Holding AG | 4.50% | ||
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.42% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.40% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.06% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.14% |
| 0QIU | Novo Nordisk A/S Class B | 2.96% | ||
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.90% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 2.72% |
| GSK | GSK plc | Healthcare | Drug Manufacturers - General | 2.69% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.98% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 1.48% |
| CSL | CSL Ltd | Healthcare | Biotechnology | 1.44% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.26% |